Cip-1/WAF1/MDA6 (p21) was determined in primary hepatocytes. Prolonged activation of the MAPK pathway in p21 ؉/؉ or p21 ؊/؊ hepatocytes caused a large decrease and increase, respectively, in DNA synthesis. Either transfection with RB antisense oligonucleotides, expression of wild type E7, or RB binding mutant E7 (C24S) proteins increased p21 levels and reduced DNA synthesis in p21 ؉/؉ hepatocytes. RB antisense oligonucleotides and E7 proteins increased apoptosis in p21
, hepatocytes. Expression of wild type E7 increased DNA synthesis above control levels in p21 ؊/؊ cells, which was additive with prolonged MAPK activation. In contrast, expression of mutant E7 did not alter DNA synthesis above control levels in p21 ؊/؊ cells and was supra-additive with prolonged MAPK activation. Antisense ablation of RB in p21 ؊/؊ hepatocytes had a weak stimulatory effect upon DNA synthesis itself but enhanced the capacity of mutant E7 protein to stimulate DNA synthesis to the same level observed using wild type E7. The ability of prolonged MAPK activation to stimulate DNA synthesis in the presence of mutant E7 and antisense RB was additive. Collectively, the present data demonstrate that loss of RB function together with loss of p21 function plays an important role in the E7-and MAPK-dependent modulation of apoptosis and DNA synthesis in primary hepatocytes.
Partial hepatectomy or dissociation followed by primary culture triggers hepatocyte entry into the cell cycle (1) (2) (3) . Maximal DNA synthesis in vivo occurs between 12-36 h post-partial hepatectomy. Primary culture in vitro in the presence of growth factors such as insulin, epidermal growth factor, or hepatocyte growth factor stimulates hepatocyte DNA synthesis that is maximally observed between 40 and 70 h post-isolation (3) (4) (5) (6) . Hepatocytes in vivo or in vitro do not terminally differentiate and can enter and exit the cell cycle during cycles of liver regeneration. This distinguishes them from many other cell types, e.g. intestinal epithelial cells and keratinocytes, which undergo irreversible terminal differentiation (7, 8) . During proliferation, hepatocytes maintain many of their differentiated hepatocellular functions (1) (2) (3) (4) (5) (6) .
Two signaling pathways leading to increased DNA synthesis in primary hepatocytes are the c-Jun NH 2 -terminal kinase and the p38-reactivating kinase pathways (4, 6) . Signaling by the p42/44 mitogen-activated protein kinase (MAPK) 1 pathway appeared to play two roles in regulating hepatocyte DNA synthesis (4, 9 -11) . A short phasic or low sustained activation of the MAPK pathway increased hepatocyte DNA synthesis, whereas high sustained MAPK activity played a prominent role in causing cell cycle arrest (9, 10) . Low level activation of the MAPK pathway correlated with expression of cyclin D1, whereas the ability of MAPK to cause cell cycle arrest correlated with increased expression of the cyclin-dependent kinase inhibitor protein p21
Cip-1/WAF1/MDA6 (p21) and to a lesser extent with the cyclin-dependent kinase inhibitor proteins p16 ink4a and p27
Kip-1 (9 -11) . Established hepatoma cells that are relatively refractile to p21 induction are more tumorigenic in vivo than hepatoma cells which still retain the ability to express p21 (12) . In part, this may be due to loss of p53 function, although several studies indicate that childhood hepatomas and early stage adult liver cancers express functional p53 (13) (14) (15) . Indeed, a reduction in the ability of many cell types to increase p21 expression may contribute to the processes of transformation and differentiation (10, 11, 16, 17) . This could be due to a loss of transcription factor function(s) or due to altered signaling via other pathways that regulate p21 expression, e.g. signaling by the RhoA GTPase (10, 18 -20) . Recently, it was shown that the relative ability of MAPK to increase p21 expression decreased in HepG2 hepatoma cells compared with primary hepatocytes (10, 11) . In further agreement with the importance of p21 expression in hepatocyte cell cycle control, inducible overexpression of p21 inhibits liver regeneration after partial hepatectomy (21) (22) (23) . Collectively, these data suggest that regulation of p21 expression and function plays pivotal roles in both the regulation of liver regeneration and in hepatocellular transformation.
Human papilloma viruses (HPV) are a family of DNA viruses that can infect, prolong the life, and transform epithelial cells, particularly in the skin, head and neck, and cervix (24 -37) . The expression of multiple viral proteins is mandatory for rapid and complete transformation. The E7 protein is the major oncogenic protein produced by cervical cancer-associated HPV16 (24 -27) . The majority of the transforming potential of E7 protein has been ascribed to its ability to bind to, and downregulate, the retinoblastoma (RB) gene product (28, 29, 30) . Loss of RB function causes the release and activation of multiple E2F transcription factor family members, leading to cell cycle progression through the G 1 /S phase transition (27) (28) (29) (30) 34) . Expression of E7 proteins can also increase protein levels of p21 (30 -37) . Depending upon the degree of E7 expression and the differentiation state of the cell type, increased p21 levels can either enhance DNA synthesis and apoptosis or cause growth arrest (30 -33) . The present studies were designed to determine the impact of MAPK signaling and of E7 protein expression upon p21 protein levels, DNA synthesis, and apoptosis in primary hepatocyte cultures.
EXPERIMENTAL PROCEDURES

Materials-Male C57BL/6J p21
ϩ/ϩ and p21 Ϫ/Ϫ (null) mice (30 g) had access to food and water ad libidum. Anti-p42 MAPK (sc-154AC), anti-C/ EBP␤ (sc-150), anti-C/EBP␣ (sc-61), anti-pRB (sc-50), anti-rodent p53 (sc-100), anti-Ets2 (sc-351), anti-c-Myc (sc-788), anti-cdk2 (sc-163AC), anti-cdk4 (sc-601AC), anti-p16
INK4a (sc-1207), anti-p21 (sc-397-G and sc-817), anti-cyclins A (sc-596), D (sc-753), and E (sc-481) were from Santa Cruz Biotechnology (Santa Cruz, CA). Radiolabeled [␥- 32 P]ATP and [
3 H]thymidine were from NEN Life Science Products. Western immunoblotting was performed using the enhanced chemiluminescence system (Amersham Pharmacia Biotech). Protein preparations and other reagents were as in Refs. 4, 6, 7, 9 -11, 10, 23, and 38 -41. Recombinant Adenoviral Vectors; Generation and Infection in VitroTwo adenoviral technologies were used. Replication defective adenovirus is conjugated to poly-L-lysine as described (6, 10, 39, 42) . For the studies described in this paper, hepatocytes were infected with kinase active ⌬B-Raf:ER, wild type E7, or mutant E7 (C24S) poly-L-lysine adenoviruses (at 250 m.o.i.). In some experiments and in addition to ⌬B-Raf:ER infection, cells were also infected with either an additional plasmid poly-L-lysine adenovirus combinations at a 100 m.o.i. Second, we generated recombinant adenoviruses (9, 43) . Infections with recombinant adenoviruses were all at 100 m.o.i. each, followed by culture as below.
Transfection of Mouse Hepatocytes with Oligonucleotides-Cells were transfected with antisense Ets2 or antisense RB phosphorothioate oligonucleotides or their corresponding sense phosphorothioate oligonucleotides as described (6, 39, 40) using Superfection© reagent at an oligonucleotide concentration of 10 M final in the media, as per the manufacturer's instructions.
Preparation of Mouse Hepatocytes-Hepatocytes were prepared as described (4, 6, 10) .
Primary Culture, Hormonal Treatment, and Assay for DNA Synthesis in Cultures of Hepatocytes-Mouse hepatocytes were cultured on rat tail collagen (Vitrogen)-coated plastic dishes (12 ϫ 20 mm, 2 ϫ 10 5 cells; 1 ϫ 100 mm, 5 ϫ 10 6 cells) in phenol red-free Dulbecco's modified Eagle's medium containing L-glutamine and sodium pyruvate in 5% (v/v) CO 2 supplemented with 50 nM insulin, 0.1 nM dexamethasone, 1 nM thyroxine. At this time, cells were infected with various adenoviruses as dependent upon the experiment. For adenoviral infected cells, 4 h after infection, media were replaced and hepatocytes cultured in the same supplemented Dulbecco's modified Eagle's medium for 24 h. Twenty four hours after infection, hepatocytes were treated with 100 nM 4-hydroxytamoxifen. Protein kinase inhibitors were added 24 h after the media change (protein kinase inhibitors were added 30 min prior to any further treatment). MAPK activity was determined prior to 4-hydroxytamoxifen addition, 6 h after the start of treatment and then a further 24 and 36 h later. Twenty seconds prior to termination, media were aspirated followed by immediate homogenization. Cells were homogenized as described (4, 6, 10) . Homogenates were stored on ice prior to clarification by centrifugation (4°C), and clarified aliquots were subjected to immunoprecipitation. For DNA synthesis assays, hepatocytes were isolated and infected with ⌬B-Raf:ER. Twenty four hours after infection, hepatocytes were treated with 100 nM 4-hydroxytamoxifen in the presence of 4 Ci of [ 3 H]thymidine/ml culture media for a further 36 h (total time 60 h), after which time cells were lysed with 0.5 M NaOH and DNA-precipitated with 12.5% (w/v) trichloroacetic acid. Acid-precipitable material was recovered and washed with 5% (w/v) trichloroacetic acid, and [
3 H]thymidine incorporation into DNA was quantified by liquid scintillation spectrometry (4, 6, 10) .
Immunoprecipitations from Homogenates-Immunoprecipitations were as described (4, 6, 10) .
Assay of MAPK Activity-Activity was determined as described (4, 6, 10) versus myelin basic protein (MBP). After reaction mixtures were spotted onto circles of P81 phosphocellulose paper (Whatman, Maidstone, UK) and immediately placed into 180 mM phosphoric acid. Papers were washed four times (10 min each) with phosphoric acid and once with acetone, and 32 P incorporation into MBP was quantified by liquid scintillation spectroscopy.
Assay of Cyclin-dependent Kinase 2 and 4 (Cdk2 and Cdk4) Activities-Cdk2 and cdk4 activities were measured in immunoprecipitates of whole cell lysates 24 h after 4-hydroxytamoxifen treatment of cells. Approximately 100 g of cellular protein from whole cell homogenates (prepared as described above) was incubated with agarose-conjugated anti-cdk2 IgG or anti-cdk4 IgG on ice in 200 l for at least 2 h each. Immune complex protein kinase assays were conducted by assaying immunoprecipitated samples in triplicate using 0.5 mg/ml histone H1 (cdk2 assays) or 2 g glutathione S-transferase-retinoblastoma (RB) protein (amino acids 379 -928) (cdk4 assays) for assays as described (10) .
Luciferase Assay-For luciferase assays, hepatocytes were isolated from p21 ϩ/ϩ and p21 Ϫ/Ϫ (null) mice and infected (at an m.o.i. of 100) with various p21 promoter constructs (full-length or containing the initiating ATG proximal 850 base pairs of the p21 promoter). In cells expressing ⌬B-Raf:ER, 24 h after infection, hepatocytes were treated with 100 nM 4-hydroxytamoxifen. Hepatocytes were cultured for a further 0 -480 min or 36 h as indicated, after which time cells were lysed with manufacturer's lysis buffer and luciferase assays performed as per manufacturer's instructions using a Bertold luminometer (Promega Luciferase assay kit) (6) .
Western Blotting-Hepatocytes were isolated and infected with various constructs. Twenty four hours after infection, in cells expressing ⌬B-Raf:ER, hepatocytes were treated with 100 nM 4-hydroxytamoxifen. Hepatocytes were cultured for a further 6 -36 h, after which time cells were lysed with either 10% (w/v) trichloroacetic acid or ice-cold homogenization buffer. For transcriptional control assays (Fig. 3 ), cells were treated for 480 min with 4-hydroxytamoxifen in the presence or absence of either 5 M actinomycin D, 30 M DRB, 20 g/ml cycloheximide. Trichloroacetic acid-precipitated protein was collected by centrifugation, washed once with cold acetone, and resuspended in SDS-PAGE sample buffer prior to resolution on SDS-PAGE using 10 -12% gels. In 35 S-labeling experiments, cells lysed in homogenization buffer were subjected to immunoprecipitation as described above, prior to resuspension in SDS-PAGE sample buffer and resolution on SDS-PAGE using 10 -12% gels. Gels were transferred to a 0.22-m nitrocellulose filter and immunoblotting performed using the ECL system (4, 6, 10) .
Determination of p21 mRNA Levels by Reverse Transcriptase-Polymerase Chain Reaction-For determination of p21 mRNA levels, hepatocytes were isolated from p21 ϩ/ϩ and p21 Ϫ/Ϫ (null) mice and infected with various constructs. In cells expressing ⌬B-Raf:ER, 24 h after infection, hepatocytes were treated with 100 nM 4-hydroxytamoxifen. Hepatocytes were cultured for a further 6 -36 h in the presence or absence of 5 M actinomycin D, after which time cells were lysed, and total RNA was prepared. RNA was subjected to 35 cycles of reverse transcriptase-polymerase chain reaction using specific oligonucleotides for mouse p21 (5ЈCCG CAC AGG AGC AAA GTG TGC; 3ЈCTT GCA GAA GAC CAA TCT GCG). Equal loading of total RNA was used for gel electrophoresis. Following agarose gel electrophoresis, RNA bands were visualized using propidium iodide staining and quantification of UVfluorescent band intensity determined using SigmaScan software (4, 44) .
Determination of Protein Half-life/Radiolabeling of p21-For determination of p21 protein stability, hepatocytes were isolated from p21 ϩ/ϩ and p21 Ϫ/Ϫ (null) mice and infected with various constructs. Twenty four hours after infection, media were replaced with methionine/cysteine-free media containing 1 Ci/10 l [
35 S]methionine. In cells expressing ⌬B-Raf:ER, 24 h after infection, hepatocytes were also treated with 100 nM 4-hydroxytamoxifen. In studies examining MAPK-mediated alterations in stability, 36 h after MAPK activation, media were replaced with media containing non-radioactive methionine/cysteine and 20 g/ml cycloheximide. Portions of cells were treated with 50 M PD98059, which abolished MAPK activity. The rate at which 35 S radioactivity was lost from p21 was determined following immunoprecipitation, SDS-PAGE, transfer to nitrocellulose, and autoradiography in control cells, MAPK-active cells, and MAPK active ϩ PD98059 cells over the following 6 h. In studies using wild type E7, 36 h after [ 35 S]methionine addition, media were replaced with media containing non-radioactive methionine/cysteine and 20 g/ml cycloheximide. The rate at which 35 S radioactivity was lost from p21 was determined as above in control cells, wild type E7-expressing cells, and mutant E7-expressing cells over the following 6 h (45, 46). Quantification of band intensity used Molecular Dynamics software.
Determination of Apoptosis/Cell Death-Hepatocytes were isolated from p21
ϩ/ϩ and p21 Ϫ/Ϫ (null) mice and infected with various constructs. Twenty four hours after infection, in cells expressing ⌬B-Raf: ER, hepatocytes were treated with 100 nM 4-hydroxytamoxifen. Hepatocytes were cultured for a further 6 -36 h. Cells were grown in 60-mm dishes as described. Cells were isolated by trypsinization followed by centrifugation onto glass slides (cytospin). Terminal uridyl-nucleotide end labeling (TUNEL) was performed on these cells as described previously. Randomly selected fields of fixed cells (n ϭ 5 per slide) were counted, initially using propidium iodide counter-stain, followed by examination and counting of TUNEL-positive staining cells (47, 48) .
Data Analysis-Comparison of the effects of various treatments is performed using one-way analysis of variance and a two-tailed t test. Differences with a p value of Ͻ0.05 were considered statistically significant. Experiments shown are the means of multiple individual points from multiple separate experiments (using hepatocytes from different animals) (ϮS.E.).
RESULTS
Prolonged Activation of the MAPK Cascade Increases p21
Cip-
1/WAF1/MDA6 (p21) Expression in Primary Mouse
HepatocytesIsolated hepatocytes were infected with a construct to express an inducible estrogen receptor-B-Raf fusion protein (⌬B-Raf: ER). Cells were treated with 4-hydroxytamoxifen as described under "Experimental Procedures," and the activity of MAPK was determined. Treatment of hepatocytes (p21 ϩ/ϩ , p21 Ϫ/Ϫ , and p21 ϩ/ϩ with p21 antisense mRNA) with 4-hydroxytamoxifen increased MAPK activity ϳ6-fold after 6 h, which increased to ϳ8-fold above basal levels 24 and 36 h after activation (Table I) . MAPK activation was blocked by incubation with the specific inhibitors of MAPK/extracellular signal-regulated protein kinase 1/2, PD98059 (50 M), and U0126 (2 M) (in agreement with Refs. 4, and 9 -11; data not shown). This prolonged MAPK activation caused an increase in p21 protein expression in p21 ϩ/ϩ hepatocytes but not in p21 Ϫ/Ϫ hepatocytes or p21 ϩ/ϩ with p21 antisense mRNA (Figs. 1, A-C) (25) . No increase in MAPK activity or p21 expression was observed in 4-hydroxytamoxifen-treated hepatocytes infected with kinaseinactive molecule (Refs. 9 -11; data not shown).
Prolonged Activation of the MAPK Cascade Increases p21 Expression via Transcriptional and Post-transcriptional Mechanisms in Primary Mouse
Hepatocytes-We next determined potential downstream mechanisms by which MAPK signaling increases p21 protein levels. Elevation of p21 expression was first observed 5 h after MAPK activation, which was maintained over the following 48 h (Fig. 2A) . Antisense ablation of C/EBP␣ or C/EBP␤, overexpression of c-Myc, antisense ablation of Ets2, or dominant negative c-Jun (TAM67) lowered basal p21 expression (Fig. 2B ). Antisense ablation of C/EBP␤, overexpression of c-Myc, antisense ablation of Ets2, or dominant negative c-Jun (TAM67) also caused varying partial reductions in MAPK-induced p21 expression. In contrast, loss of C/EBP␣ function abolished MAPK-induced p21 expression. Transfection of cells with antisense c-Myc enhanced basal p21 levels and potentiated MAPK induction of p21, whereas neither basal nor enhanced p21 levels were reduced by expression of dominant negative p53 (R175H) (data not shown (9, 20) ).
The next set of studies were designed to determine the downstream mechanism(s) by which MAPK signaling increases p21 protein levels. Inhibitors of transcription partially blocked MAPK signaling to induce p21 protein expression after 7 h by ϳ50% (Fig. 3A) . Prolonged MAPK signaling increased p21 promoter activity 9.10 Ϯ 0.25-fold within 8 h from a full-length p21 promoter construct coupled to the luciferase gene product; this stimulation was lost from a truncated (Ϫ850) p21 promoter ϩ/ϩ hepatocytes; B, p21 Ϫ/Ϫ hepatocytes; C, p21 ϩ/ϩ hepatocytes with p21 antisense mRNA. Hepatocytes were infected with ⌬B-Raf:ER poly-L-lysine adenovirus and/or with either a null recombinant adenovirus or a p21 antisense mRNA recombinant adenovirus followed by culture as under "Experimental Procedures." After 24 h, hepatocytes were treated with either vehicle control or with 4-hydroxytamoxifen for 36 h. Protein expression of p21 was determined by immunoblotting. construct (data not shown). Increased promoter-luciferase activity correlated with the MAPK-induced 2.00 Ϯ 0.15-fold increase in p21 mRNA levels as determined by reverse transcriptase-polymerase chain reaction. The levels of p21 mRNA were maintained by MAPK activation at basal values in the presence of inhibitors of transcription, whereas in control cells, which had their transcription inhibited, these levels declined (data not shown).
To determine whether MAPK signaling increases the stability of p21 protein, pulse-chase experiments were performed in which cells were incubated with [ 35 S]methionine in the presence of active MAPK. After induction of p21 expression, cells were incubated in media containing non-radioactive methionine. The rate at which 35 S radioactivity was lost from immunoprecipitated p21 protein was determined (Fig. 3B) . Activation of MAPK increased the half-life of radiolabeled p21 protein from ϳ45 to ϳ120 min. Incubation with PD98059 blunted this increase in protein stability. Treatment with cycloheximide prior to addition of [ 35 S]methionine abolished radiolabel incorporation into p21 protein but did not alter the increase in stability of radiolabeled p21 protein (data not shown). Collectively, these data demonstrate that MAPK-induced p21 protein expression is due to a combination of an increased rate of transcription from the p21 promoter as well as increased p21 mRNA and protein stabilities.
Prolonged MAPK Activation Inhibits Cdk2 and Cdk4 in p21
ϩ/ϩ but Not in p21 Ϫ/Ϫ Hepatocytes and Promotes DNA Synthesis in the Absence of p21 Expression-Parallel experiments were performed examining whether prolonged MAPK signaling alters the activities of cdk2 and cdk4 in hepatocytes. Prolonged activation of MAPK reduced cdk2/cdk4 activities in p21 ϩ/ϩ hepatocytes but increased cdk2/cdk4 activities in p21 Ϫ/Ϫ hepatocytes and in p21 ϩ/ϩ hepatocytes expressing antisense p21 mRNA (data not shown; in agreement with Ref. 10 ). Expression of cyclin D1 was enhanced by activation of MAPK in primary hepatocytes (Fig. 4A) . Prolonged activation of MAPK also increased phosphorylation of the RB gene product in hepatocytes incapable of expressing p21, as judged by the reduced migration of RB protein species after SDS-PAGE (Fig. 4B) .
The impact of prolonged MAPK activity to alter [ 3 H]thymidine incorporation into DNA was next determined. Prolonged MAPK activity reduced DNA synthesis in p21 ϩ/ϩ hepatocytes, whereas it increased DNA synthesis in p21 Ϫ/Ϫ hepatocytes (Table II) . Expression of p21 antisense mRNA in p21 ϩ/ϩ hepatocytes blocked the ability of prolonged MAPK activation to increase p21 expression but permitted the ability of this stimulus to increase DNA synthesis (Table II) . These data support the view that the mechanism by which prolonged MAPK signaling inhibits G 1 phase cdk activities and DNA synthesis in primary cultures of hepatocytes is via increasing protein levels of p21.
Expression of Human Papilloma Virus E7 Proteins Increases Expression of p21 in p21
ϩ/ϩ Hepatocytes-To examine the impact of HPV16 E7 expression on p21 protein levels, hepatocytes were infected with constructs expressing either wild type E7 protein that down-regulates RB protein levels or mutant E7 (C24S) protein that weakly binds to RB (49) . Expression of wild type, but not mutant, E7 abolished protein levels of RB (Fig.  5A) (29, 37) . Mutant E7 protein weakly decreased RB expression by only ϳ20%. Expression of wild type E7, and to a lesser extent mutant E7 (C24S), proteins increased protein levels of p21 (Fig. 5B) .
We next investigated how expression of E7 proteins increase p21 levels in hepatocytes. Surprisingly, expression of either wild type or mutant E7 protein decreased luciferase activity by ϳ90 and ϳ40%, respectively, from a full-length p21 promoter (Fig. 5C ), but in contrast very weakly reduced p21 mRNA levels (data not shown). To determine whether E7 proteins increase the stability of p21 protein, pulse-chase experiments were performed in which cells were incubated with [
35 S]methionine for 60 h. The rate at which 35 S radioactivity was lost from p21 protein was determined (Fig. 5D ). In the absence of wild type E7 expression, the half-life of p21 protein was ϳ45 min. In contrast, expression of wild type E7 increased the half-life of p21 protein to at least ϳ150 min. These data suggest that E7 proteins may enhance the stability of both p21 mRNA and protein.
Antisense RB Decreases Expression of RB and Increases Expression of p21 in p21
ϩ/ϩ Hepatocytes-Since HPV16 wild type E7 expression decreases RB and increases p21 protein levels, we next examined whether direct RB protein down-modulation was causally related to enhanced p21 protein levels. Hepatocytes were transfected with oligonucleotides to express either an antisense RB oligonucleotide or a sense oligonucleotide (37) . Expression of antisense RB, but not sense RB, oligonucleotide abolished RB protein levels and caused a small ϳ2-fold increase in the protein levels of p21 (Fig. 6A) . However, antisense RB significantly increased luciferase activity ϳ5-fold from a full-length p21 promoter (Fig. 6B) . These data suggest that loss of RB expression increases p21 protein levels via a transcriptional mechanism.
Expression of Wild Type and Mutant E7 Proteins Inhibit DNA Synthesis and Increase Apoptosis in p21
ϩ/ϩ Hepatocytes but Not in p21 Ϫ/Ϫ -Several studies argue that expression of wild type E7 increases apoptosis without inhibiting proliferation, even in the presence of elevated p21 expression (30 -33, 35-37) . Since we observed that wild type E7 potently increased p21 expression, we next investigated whether E7 protein altered cell viability as well as DNA synthesis in primary hepatocytes. Expression of wild type, and to a lesser extent mutant E7, increased apoptosis in primary hepatocytes capable of expressing p21 but not in hepatocytes incapable of p21 expression (Fig. 7A) . Similarly, expression of wild type E7 protein decreased DNA synthesis in p21 ϩ/ϩ hepatocytes, whereas this protein stimulated DNA synthesis in hepatocytes incapable of p21 expression (Fig. 7B) . In contrast, mutant E7 protein weakly inhibited hepatocyte DNA synthesis in p21 ϩ/ϩ hepatocytes and had a neutral effect on DNA synthesis in hepatocytes that were p21-deficient.
RB Antisense Oligonucleotides Increase Apoptosis and Decrease DNA Synthesis in p21
ϩ/ϩ Hepatocytes, Whereas They Do Not Cause Death and Enhance DNA Synthesis in p21 Ϫ/Ϫ Cells-Fan et al. (40) reported that antisense RB oligonucleotides cause apoptosis in primary hepatocytes. Since E7 proteins increased p21 expression and caused apoptosis, and antisense RB oligonucleotides also increased p21 levels, we next determined whether the apoptotic response was dependent upon p21 expression. Transfection of antisense, but not sense, RB oligonucleotides increased apoptosis in p21 ϩ/ϩ cells but had little effect in p21 Ϫ/Ϫ cells (Fig. 8A) . Confirming this observation, we found that antisense RB oligonucleotides also reduced DNA synthesis in p21 ϩ/ϩ cells and caused a small ϳ1.3-fold stimulation of DNA synthesis in p21 Ϫ/Ϫ cells (Fig. 8B) .
Loss of RB Function Enhances the Ability of E7 Mutant Protein to Stimulate DNA Synthesis in p21
Ϫ/Ϫ HepatocytesMutant E7 was unable to abolish RB expression or to stimulate DNA synthesis in p21 Ϫ/Ϫ hepatocytes, whereas wild type E7 reduced RB levels and increased DNA synthesis in these cells (Fig. 7) . These data suggest that RB function has an inhibitory effect upon the ability of mutant E7 protein to stimulate DNA synthesis in p21 Ϫ/Ϫ cells. To test this hypothesis, p21 Ϫ/Ϫ hepatocytes were infected with either control plasmid, wild type E7 plasmid, or mutant E7 plasmid and were transfected with either RB antisense or sense oligonucleotides. Loss of RB function by itself caused a modest increase in DNA synthesis in control infected p21 Ϫ/Ϫ hepatocytes and was additive with wild type E7 expression in enhancing DNA synthesis. In contrast, loss of RB function permitted mutant E7 protein to stimulate DNA synthesis in p21 Ϫ/Ϫ hepatocytes to an identical extent observed when cells were expressing wild type E7 protein (Fig.  9 ). These data suggest that loss of RB function together with loss of p21 function play an important role in the E7-dependent stimulation of DNA synthesis in primary hepatocytes.
Activation of ⌬B-Raf:ER Enhances the Ability of E7 Proteins to Stimulate DNA Synthesis in Hepatocytes That Do Not Ex
press p21-Since either E7 expression or signaling by ⌬B-Raf:ER can increase p21 levels, we next investigated whether ⌬B-Raf:ER signaling could impact upon the ability of E7 to alter DNA synthesis in primary hepatocytes. Prolonged activation of MAPK reduced DNA synthesis in p21 ϩ/ϩ hepatocytes, an effect that was not altered by expression of either wild type or mutant E7 protein (Fig. 10A) . Expression of wild type E7 and prolonged MAPK activity were additive in stimulating DNA synthesis in p21 Ϫ/Ϫ cells, whereas expression of mutant E7 and prolonged MAPK activity were supra-additive in stimulating DNA synthesis (Fig. 10B) . Figs. 8 -10 , we determined whether loss of RB function in primary hepatocytes modifies the level of DNA synthesis in response to prolonged MAPK signaling. Either prolonged MAPK signaling or transfection with RB antisense oligonucleotides decreased DNA synthesis in p21 ϩ/ϩ hepatocytes (Fig. 11A) . However, loss of RB function permitted prolonged MAPK signaling to cause a small, but significant, increase in DNA synthesis in these cells. In p21 Ϫ/Ϫ hepatocytes prolonged MAPK signaling increased DNA synthesis 2.5-fold, whereas transfection with RB antisense oligonucleotides only caused a modest increase in DNA synthesis. Loss of RB function combined with prolonged MAPK signaling resulted in an approximate additive increase in DNA synthesis in p21 Ϫ/Ϫ hepatocytes (Fig. 11B) .
Loss of RB Function Enhances the Ability of to ⌬B-Raf:ER to Stimulate DNA Synthesis in Hepatocytes-Based on the data presented in
Loss of RB Function Reduces Mutant E7 Protein Synergy with ⌬B-Raf:ER in the Stimulation of DNA Synthesis-Loss of RB function using antisense RB transfection weakly stimulated DNA synthesis in p21
Ϫ/Ϫ cells (Figs. 8 and 9 ). Similarly, expression of mutant E7 did not increase DNA synthesis in these cells. However, transfection of an antisense RB oligonucleotide facilitated mutant E7-mediated stimulation of DNA synthesis to a comparable level seen when expressing wild type E7 alone. Furthermore, prolonged MAPK activation in p21 Ϫ/Ϫ cells caused supra-additive increases in DNA synthesis under conditions of mutant, but not wild type, E7 expression. Because of these findings, we examined the impact of combined mutant E7 and RB antisense treatments upon DNA synthesis in the presence or absence of prolonged MAPK signaling. Prolonged MAPK signaling stimulation of DNA synthesis was additive when p21
Ϫ/Ϫ cells co-expressed mutant E7 and RB antisense oligonucleotide (Fig. 12) , whereas it was supra-additive with the co-expression of mutant E7 and RB sense oligonucleotide ( Fig. 10; data not shown) . Collectively, the findings presented in Table II and Figs. 5-12 demonstrate that loss of p21 and/or RB function increases the ability of prolonged MAPK signaling to promote DNA synthesis in primary hepatocytes.
DISCUSSION
The present studies were performed to determine the impact of MAPK signaling and of transforming E7 proteins upon p21 expression, DNA synthesis, and apoptosis in primary cultures of hepatocytes. Prolonged activation of the MAPK pathway inhibited cdk2/cdk4 activities and reduced DNA synthesis in p21 ϩ/ϩ hepatocytes. No alteration was observed in the low basal level of apoptosis. However in both p21 Ϫ/Ϫ hepatocytes and in p21 ϩ/ϩ hepatocytes expressing antisense p21 mRNA, prolonged activation of the MAPK pathway potently increased cdk activities. MAPK activation enhanced cyclin D1 expression, and in both p21
Ϫ/Ϫ and in p21 ϩ/ϩ hepatocytes expressing antisense p21 mRNA, also with enhanced phosphorylation and inactivation of the RB gene product. Prolonged MAPK signaling inhibited DNA synthesis in p21 ϩ/ϩ hepatocytes but stimulated DNA synthesis in both p21
Ϫ/Ϫ hepatocytes and in p21
ϩ/ϩ hepatocytes expressing antisense p21 mRNA. These data demonstrate that p21 was responsible for the reduction in DNA synthesis in response to prolonged MAPK activation. That prolonged MAPK signaling did not cause growth arrest in p21 null primary hepatocytes was not entirely expected, since they possess a functional RB protein and express p16 ink4a in response to MAPK signaling (10) . Increased expression of p16 ink4a would be expected to inhibit cdk4 activity, blocking both RB phosphorylation and its inactivation. The present data confirm that p21 plays a prominent role in regulating cdk4 activity and cell cycle progression in hepatocytes, a similar conclusion suggested by other investigators (21, 22) .
The downstream mechanism(s) by which the MAPK pathway increases protein levels of p21 were also examined. Antisense ablation of the transcription factor C/EBP␣ abolished the MAPK-mediated increase in p21 protein levels (50, 51) . Elevated expression of c-Myc, antisense oligonucleotides toward C/EBP␤, antisense oligonucleotides toward Ets 2, or dominant negative c-Jun(TAM67) partially affected basal p21 protein levels and had varying effects at reducing MAPK induction of p21. However, little effect was observed in cells expressing either dominant negative p53 (K175H) (46, (52) (53) (54) (55) (56) (57) . Elevated MAPK signaling increased activity from a full-length p21-promoter construct and enhanced p21 mRNA levels. These data suggest that one mechanism by which MAPK signaling increases p21 protein levels is by enhancing transcription from the p21 promoter and that this increase may be mediated by multiple transcription factors. Collectively, the present data demonstrate that multiple positive and negative signals, at the level of transcription factors, impinge upon the activity of the p21 promoter.
Inhibitors of transcription that blocked MAPK induction of p21 mRNA and increased mRNA stability only partially blunted the MAPK-induced increased expression of p21 protein. Further experiments demonstrated that MAPK signaling approximately doubled the stability of p21 protein. Collectively, these data argue that MAPK signaling increases p21 protein levels in primary hepatocytes via three mechanisms as follows: by enhanced transcription, by enhanced mRNA stability, and by enhanced protein stability. This is in general agreement with data of Zeng and El-Deiry (55) who obtained similar results analyzing protein kinase C activation on the regulation of p21 protein levels.
Data from several laboratories have suggested that MAPK signaling can induce p21 expression by both p53-dependent and p53-independent mechanisms (10, 11, 58 -62) . The ability of MAPK signaling to increase p21 expression in primary hepatocytes was independent of p53, which is in general agreement with data of Serfas et al. (20) who demonstrated that the ability of carbon tetrachloride to increase p21 expression in hepatocytes in vivo was p53-independent. However, we have found that in other hepatocyte-derived cell types, e.g. HepG2 hepatoma cells, MAPK-induced expression of p21 is p53-dependent 2 (63) . These data are consistent with the possibility that p53-independent mechanisms downstream of MAPK and upstream of the p21 protein, which are functional in primary hepatocytes, may be defective in hepatoma cells. Several reports have examined, using passaged epithelial cells which are capable of undergoing irreversible terminal differentiation, the role of transforming viral proteins on growth control and apoptosis. In these studies, HPV16 E7 protein abolished RB expression and stimulated both DNA synthesis and apoptosis, in the presence of enhanced p21 protein levels. Because prolonged MAPK signaling can also inactivate RB function and stimulate DNA synthesis in p21 Ϫ/Ϫ cells (59, 60) , the ability of E7 protein to alter cell cycle progression in non-established epithelial cells, which can senesce but do not 2 P. Dent et al., unpublished data.
FIG. 5.
Wild type E7 protein abolishes RB expression and increases the protein stability of p21. A, E7 abolishes RB expression; B, E7 increases p21 protein levels; C, E7 decreases p21 promoter activity; D, E7 maintains p21 mRNA levels; E, E7 increases p21 protein stability. Hepatocytes were infected with either wild type E7 or mutant E7 (C24S) or with a plasmid containing full-length p21 promoter, poly-L-lysine adenoviruses followed by culture as under "Experimental Procedures." A and B, expression of E7 proteins, p21 and RB was determined by immunoblotting. C, cells were infected with plasmids to express E7 proteins and with a plasmid containing full-length p21 promoter. Luciferase activity was determined as described under "Ex- terminally differentiate primary hepatocytes, was examined.
HPV16 wild type E7 protein abolished RB protein expression in hepatocytes, whereas a point mutant (C24S) E7 protein caused only a small reduction in RB levels. Expression of wild type E7 protein caused a large increase in p21 expression, whereas mutant E7 protein only caused a modest increase in p21 levels. Based on these findings, we found to our surprise that both E7 proteins decreased p21 promoter activity. Enhanced p21 protein levels were due to E7-dependent increases in p21 mRNA and protein stability. In a similar manner to mutant E7 protein expression, antisense ablation of RB caused a modest increase in p21 protein levels but in contrast increased luciferase activity from the p21 promoter. These data argue that loss of RB function can increase p21 protein levels via both transcriptional and post-transcriptional mechanisms.
Antisense ablation of RB expression as well as expression of HPV16 wild type E7 protein have previously been reported to cause apoptosis and paradoxically to increase DNA synthesis in cells (28 -37) . In agreement with these findings, both expression of wild type E7 or transfection with antisense RB significantly enhanced apoptotic double-stranded DNA breaks in p21 ϩ/ϩ cells. However unlike previous reports in other cell types, both expression of wild type E7 or transfection of antisense RB in p21 ϩ/ϩ primary hepatocytes was associated with decreased DNA synthesis. Mutant E7 protein reduced DNA synthesis but to a lesser extent than observed with wild type protein.
Studies performed in p21 Ϫ/Ϫ cells demonstrated that neither wild type E7 nor antisense RB increased apoptosis and, in contrast to our findings in cells that could express p21, actually FIG. 7 . E7 protein increases apoptosis and decreases DNA synthesis in p21 ؉/؉ hepatocytes, whereas it does not cause death and enhances DNA synthesis in p21 ؊/؊ hepatocytes. A, E7 proteins increase apoptosis in p21 ϩ/ϩ , but not in p21 Ϫ/Ϫ , hepatocytes. B, E7 proteins inhibit DNA synthesis in p21 ϩ/ϩ hepatocytes; wild type E7 protein stimulates DNA synthesis in p21 Ϫ/Ϫ hepatocytes, whereas mutant E7 protein has no effect. Hepatocytes were infected with either wild type E7 or mutant E7 (C24S) poly-L-lysine adenoviruses followed by culture as described under "Experimental Procedures." A, 60 h after infection, cells were isolated, and slides were made and stained for apoptotic double-stranded DNA breaks (TUNEL) as described under "Experimental Procedures." Data are the means of three separate experiments (ϮS.E.). **, p Ͻ 0.001 greater than control; *, p Ͻ 0.05 greater than control. B, 24 h after infection, hepatocytes were incubated with [
3 H]thymidine for 36 h, after which they were lysed, and [ 3 H]thymidine incorporation into DNA was determined as described under "Experimental Procedures." Data are the means of eight separate experiments (ϮS.E.). ##, p Ͻ 0.001 less than control; $, p Ͻ 0.05 less than control and greater than E7 wild type expression; *, p Ͻ 0.01 greater than vehicle control.
FIG. 8. RB antisense oligonucleotides increase apoptosis and decrease DNA synthesis in p21
؉/؉ hepatocytes, whereas they do not cause death and enhance DNA synthesis in p21 ؊/؊ hepatocytes. A, RB antisense oligonucleotides increases apoptosis in p21 ϩ/ϩ , but not in p21 Ϫ/Ϫ , hepatocytes. B, RB antisense oligonucleotides inhibit DNA synthesis in p21 ϩ/ϩ hepatocytes and cause a modest increase in DNA synthesis in p21 Ϫ/Ϫ hepatocytes. Hepatocytes were transfected with either antisense or sense RB oligonucleotides, followed by culture as under "Experimental Procedures." A, 60 h after infection, cells were isolated, and slides were made and stained for apoptotic doublestranded DNA breaks (TUNEL) as described under "Experimental Procedures." Data are the means of three separate experiments (ϮS.E.). **, p Ͻ 0.01 greater than control. B, 24 h after infection, hepatocytes were incubated with [ 3 H]thymidine for 36 h, after which they were lysed, and [ 3 H]thymidine incorporation into DNA was determined as described under "Experimental Procedures." Data are the means of seven separate experiments (ϮS.E.). #, p Ͻ 0.05 less than RB sense control; *, p Ͻ 0.05 greater than RB sense control.
enhanced DNA synthesis. Mutant E7 protein did not alter DNA synthesis in p21 Ϫ/Ϫ cells. However, mutant E7 protein expression in the context of antisense RB increased DNA synthesis which was comparable to that of wild type E7 expression alone. Collectively, these data argue that E7-and RB antisense-induced increases in p21 protein levels constitute a pro-apoptotic signal, whereas either MAPK-induced or cytotoxic stress-induced p21 has been proposed to play a protective role from cell death (64) . Thus elevated p21 protein expression can play a context-dependent pro-apoptotic or anti-apoptotic signal. Our findings also suggest that elevated p21 expression plays a key role in the ability of wild type E7 protein and antisense downregulation of RB to blunt DNA synthesis in primary hepatocytes. Furthermore, wild type and mutant E7 proteins contain a function that can stimulate DNA synthesis in cells that are lacking both RB expression and p21 function.
Since either wild type E7 expression or prolonged MAPK signaling increase DNA synthesis in p21 Ϫ/Ϫ cells but decrease DNA synthesis in p21
ϩ/ϩ cells, we next examined the impact of E7 expression combined with MAPK activation in hepatocytes. Expression of either wild type or mutant E7 proteins combined with MAPK activation in p21 ϩ/ϩ hepatocytes abolished DNA synthesis, which was less than either treatment alone. In contrast, expression of wild type E7 protein combined with MAPK activation caused an additive increase in DNA synthesis in p21 Ϫ/Ϫ cells, whereas expression of mutant E7 protein combined with MAPK activation caused an supra-additive increase in DNA synthesis in these cells. Since MAPK signaling can increase cdk activities in p21 Ϫ/Ϫ cells, which in turn downregulate RB function, our data suggest that the supra-additive effect observed with mutant E7 may be due to the inability of mutant E7 to abolish RB expression.
Since wild type, but not mutant, E7 down-regulated RB protein levels, we determined whether transfection with RB antisense oligonucleotides could complement mutant E7 expression in p21 Ϫ/Ϫ hepatocytes to enhance DNA synthesis. Loss of RB function enhanced the ability of mutant E7 to stimulate DNA synthesis in p21 Ϫ/Ϫ hepatocytes to a level comparable to that observed using wild type E7 alone. Collectively, these data suggest that reduction of RB protein levels can functionally complement mutant E7 protein expression in terms of increasing hepatocyte DNA synthesis in p21 Ϫ/Ϫ cells. However, since RB antisense oligonucleotides did not by themselves cause a large increase in DNA synthesis in p21 Ϫ/Ϫ cells, in contrast to wild type E7 protein, our data also suggest that E7 proteins enhance DNA synthesis via another RB-independent signal. Expression of RB masks this signal. Wild type or mutant E7 protein did not enhance either MAPK or c-Jun NH 2 -terminal kinase activity, which argues against these signaling pathways playing a role in the ability of E7-mediated stimulation of DNA synthesis. 2 Collectively, the findings described in this article suggest that even in the absence of p21 expression, loss of RB function is not sufficient to enhance the basal rate of DNA synthesis in ϩ/ϩ cells which is augmented by prolonged MAPK activation. B, expression of wild type E7 and mutant E7 proteins are additive and supra-additive, respectively, with MAPK-stimulated DNA synthesis in p21 Ϫ/Ϫ cells. Hepatocytes were infected with ⌬B-Raf:ER poly-L-lysine adenovirus and either wild type E7, mutant E7, or an additional null plasmid poly-L-lysine adenovirus followed by culture as under "Experimental Procedures." After 24 h, hepatocytes were incubated with [ 3 H]thymidine and treated with either vehicle control or with 4-hydroxytamoxifen for 36 h. After 36 h the cells were lysed, and [ 3 H]thymidine incorporation into DNA was determined as described under "Experimental Procedures." Data are the means of eight separate experiments (ϮS.E.). #, p Ͻ 0.05 less than ⌬B-Raf:ER ϪTAM control; $, p Ͻ 0.05 less than ⌬B-Raf:ER ϪTAM control and greater than E7 wild type; *, p Ͻ 0.05 greater than ⌬B-Raf:ER ϪTAM control; @, p Ͻ 0.05 greater than ⌬B-Raf:ER ϩTAM.
primary hepatocytes and that another signal, e.g. enhanced MAPK activity, is required for cell cycle progression. The present study underscores the complexity of cell signaling events and cell cycle-regulated gene expression changes that orchestrate cell cycle control in primary hepatocytes. hepatocytes is reduced when RB function is abolished. Hepatocytes were infected with both ⌬B-Raf:ER and mutant E7 poly-L-lysine adenoviruses and were also transfected with either antisense or sense RB oligonucleotides, followed by culture as under "Experimental Procedures." After 24 h, hepatocytes were incubated with [
3 H]thymidine and treated with either vehicle control or with 4-hydroxytamoxifen for 36 h. After 36 h the cells were lysed, and [
3 H]thymidine incorporation into DNA was determined as described under "Experimental Procedures." Data are the means of eight separate experiments (ϮS.E.). *, p Ͻ 0.05 greater than ϪTAM control; &, p Ͻ 0.05 greater than ⌬B-Raf:ER and RB sense ϩTAM value.
